Rhythm Pharmaceuticals CFO Sells 42,120 Shares
Smith Hunter C, Chief Financial Officer of Rhythm Pharmaceuticals(NASDAQ:RYTM), reported mixed transactions totaling 42,120 shares on July 9, 2025, as disclosed in an SEC Form 4 filing, resulting in post-transaction holdings of 116,915 shares.
How do the post-transaction holdings position the insider relative to ownership trends?
After the transaction, Smith Hunter C retains 116,915 shares, representing approximately 0.1838% insider ownership as of the latest available data, which is modest and consistent with ongoing reduction in net holdings over recent quarters.
What market context surrounds this transaction?
The transaction occurred with shares priced at $80.48, while the closing price on July 14, 2025, was $89.15, reflecting a price increase of 10.8% from the transaction price on July 11, 2025, to the closing price on July 15, 2025, and a 71.77% one-year total return on a calendar year basis.
Source Fool.com
